Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Hims & Hers Health shares jumped some 20% to a record high on Wednesday following the announcement that it acquired lab ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

US markets faced a tough week in 2025 amid inflation fears & weak economic data. Discover how top stocks like SMCI, BABA, and ...

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...

New service will enable blood testing for hormone levels, cardiac risk, thyroid function, and more using a blood lancet.

HIMS stock plunged by 18% after the FDA news that resolved a shortage of weight-loss drugs like Ozempic and Wegovy, which ...

The acquisition of Trybe Labs, marketed as Sigmund NJ LLC, will enable Hims & Hers to offer comprehensive whole body testing, including at-home blood draws. This addition to the company’s services is ...

Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab ...

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab ...